The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha
- PMID: 16374460
- DOI: 10.1038/sj.jid.5700070
The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha
Abstract
Advanced glycation end products (AGEs) form non-enzymatically from reactions of proteins with reducing sugars. In the skin, AGEs were reported to accumulate in dermal elastin and collagens and to interact nonspecifically with the cell membrane of dermal fibroblasts. Therefore, AGEs may influence the process of skin aging. We investigated the presence of the AGE receptor RAGE in skin and the influence of AGEs on receptor expression and the formation of extracellular matrix (ECM). Sections of sun-protected and sun-exposed skin were analyzed with monoclonal antibodies against (RAGE), heat-shock protein 47, factor XIIIa, CD31, and CD45. RAGE was mainly expressed in fibroblasts, dendrocytes, and keratinocytes and to a minor extent in endothelial and mononuclear cells. Human foreskin fibroblasts (HFFs) highly expressed RAGE on the protein and mRNA level when analyzed by quantitative Western blotting and real-time PCR. Incubation of HFFs with the specific RAGE ligand Nepsilon-(carboxymethyl)lysine-modified BSA (CML-BSA) and tumor necrosis factor-alpha resulted in significant upregulation of RAGE expression. CML-BSA induced a mildly profibrogenic pattern, increasing connective tissue growth factor, transforming growth factor-beta (TGF-beta) 1, and procollagen-alpha1(I) mRNA, whereas expression of matrix metalloproteinase (MMP)-1, -2, -3, and -12 was unaffected. We conclude that in HFFs, AGE-RAGE interactions may influence the process of skin aging through mild stimulation of ECM gene expression.
Similar articles
-
Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.J Diabetes. 2015 Jan;7(1):114-24. doi: 10.1111/1753-0407.12154. Epub 2014 Apr 29. J Diabetes. 2015. PMID: 24666836
-
Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes.Exp Dermatol. 2012 Feb;21(2):123-9. doi: 10.1111/j.1600-0625.2011.01408.x. Exp Dermatol. 2012. PMID: 22229442
-
Advanced glycation end products affect growth and function of osteoblasts.Clin Exp Rheumatol. 2011 Jul-Aug;29(4):650-60. Epub 2011 Aug 31. Clin Exp Rheumatol. 2011. PMID: 21906430
-
Advanced glycation end products and the progressive course of renal disease.Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S100-6. doi: 10.1053/ajkd.2001.27414. Am J Kidney Dis. 2001. PMID: 11576932 Review.
-
The different isoforms of the receptor for advanced glycation end products are modulated by pharmacological agents.Clin Hemorheol Microcirc. 2010;45(2-4):143-53. doi: 10.3233/CH-2010-1292. Clin Hemorheol Microcirc. 2010. PMID: 20675894 Review.
Cited by
-
Photocatalytic glucose depletion and hydrogen generation for diabetic wound healing.Nat Commun. 2022 Sep 27;13(1):5684. doi: 10.1038/s41467-022-33475-7. Nat Commun. 2022. PMID: 36167814 Free PMC article.
-
Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis.J Immunol. 2013 Apr 15;190(8):4324-36. doi: 10.4049/jimmunol.1202045. Epub 2013 Mar 11. J Immunol. 2013. PMID: 23479230 Free PMC article.
-
Advanced glycation end products (AGEs) promote melanogenesis through receptor for AGEs.Sci Rep. 2016 Jun 13;6:27848. doi: 10.1038/srep27848. Sci Rep. 2016. PMID: 27293210 Free PMC article.
-
Oxidative stress in aging human skin.Biomolecules. 2015 Apr 21;5(2):545-89. doi: 10.3390/biom5020545. Biomolecules. 2015. PMID: 25906193 Free PMC article. Review.
-
Inhibitory Effects of Parachlorella Beijerinckii Extracts on the Formation of Advanced Glycation End Products and Glycative Stress-Induced Inflammation in an In Vitro Skin Dermis-Like Model.Evid Based Complement Alternat Med. 2022 Nov 1;2022:8789903. doi: 10.1155/2022/8789903. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36387367 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous